NCT05088317

Brief Summary

Volunteer female and male individuals aged 20-65 years, followed in the State Hospital Internal Diseases Unit, diagnosed with obesity (BMI\> 30 kg/m\^2), and meeting the inclusion criteria will be included in the study. The control group will consist of healthy male and female individuals between the ages of 20-65 who have not been diagnosed with obesity. The demographic and clinical characteristics of the participants who voluntarily accepted to participate in the study will be questioned with the "Evaluation Form" prepared by the researchers, and the body compositions of the participants will be evaluated. The "Charlson Comorbidity Index (CCI)" will be used to determine the existing chronic diseases of the participants and to evaluate participants' comorbidities. Next; the "Incremental Shuttle Walk Test (ISWT)" will be applied to determine exercise capacity. In addition, in order to determine the level of physical activity, a "pedometer" device will be given to the participants, participants will be asked to carry the device on them for 7 days, and at the end of the period, the pedometer data will be recorded. At the same time, participants will be required to fill in the "International Physical Activity Questionnaire-Short Form (IPAQ-SF)". Participants will be asked to fill in the "Stop-Bang Test" to assess the risk of sleep apnea, the "Obesity-Specific Quality of Life Scale (OSQOL)" to assess the health-related quality of life, and the "Hospital Anxiety and Depression Scale (HADS)" to determine the anxiety and depression level of the participants. Handgrip strength will be evaluated with a hydraulic hand dynamometer. Assessments take an average of 45 minutes is planned.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 4, 2021

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

September 24, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2022

Completed
Last Updated

August 16, 2023

Status Verified

August 1, 2023

Enrollment Period

1 year

First QC Date

September 24, 2021

Last Update Submit

August 15, 2023

Conditions

Keywords

obesityexercise capacityphysical activitysleep apneaquality of lifeanxietydepressionhand grip strength

Outcome Measures

Primary Outcomes (5)

  • The Incremental Shuttle Walk Test

    The incremental shuttle walking test at increasing speed is one of the field tests used to evaluate exercise capacity. This test is an exercise test in which walking between two cones 10 m apart at increasing speed for 12 minutes is counted as one sit-up for each 10-meter walk between the two cones. It is continued until the patient is unable to continue the test due to shortness of breath, the heart rate reaches 85% of the maximum expected heart rate, or completes the 12-minute test. In this test, the primary measure is the distance walked, and the result is calculated based on the number of shuttles completed.

    Baseline

  • Pedometer

    The pedometer is a cost-effective, easy-to-understand device that is usually worn on the waist with an apparatus, which allows to objectively evaluate the level of physical activity, measures the number of steps.

    The pedometer will be given to the participants on the day the participants are evaluated and it will be taken back after 7 days. At the end of 7 days, the total number of steps will be recorded.

  • International Physical Activity Questionnaire-Short Form

    It is a questionnaire used to record the duration of physical activity at different levels in the last week.

    Baseline

  • Stop-Bang Test

    The Stop-Bang Test is one of the screening tests used to evaluate the risk of obstructive sleep apnea.

    Baseline

  • Obese-Specific Quality of Life Scale

    Obese-Specific Quality of Life Scale: The scale consists of 17 items and is a six-point Likert type. The scale is reverse scored and the total score is 102. When the total score approaches zero, it indicates that the quality of life of the individuals decreases, and when it approaches 100, the quality of life increases.

    Baseline

Secondary Outcomes (2)

  • Hospital Anxiety and Depression Scale

    Baseline

  • Hydraulic Hand Dynamometer

    Baseline

Study Arms (2)

Obese group

Volunteer female and male individuals aged 20-65 years, followed in an Internal Diseases unit of a state hospital in Turkey, diagnosed with obesity (BMI\> 30 kg/m\^2), who met the inclusion criteria of the study.

Diagnostic Test: Exercise capacity

Healthy group

Healthy male and female individuals between the ages of 20-65 who were not diagnosed with obesity and volunteered to participate in the study.

Diagnostic Test: Exercise capacity

Interventions

Exercise capacityDIAGNOSTIC_TEST

The incremental shuttle walking test at increasing speed (ISWT) is one of the field tests used to evaluate exercise capacity. It has been shown that ISWT is a valid and reliable assessment tool that can be used to evaluate exercise capacity in obese individuals. This test is an exercise test in which walking between two cones 10 m apart at increasing speed for 12 minutes is counted as one sit-up for each 10-meter walk between the two cones. It is continued until the patient is unable to continue the test due to shortness of breath, the heart rate reaches 85% of the maximum expected heart rate, or completes the 12-minute test. In this test, the primary measure is the distance walked, and the result is calculated based on the number of shuttles completed.

Healthy groupObese group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The obese population will consist of participants diagnosed with obesity (BMI\> 30 kg/m\^2), followed by the Tuzla State Hospital Internal Diseases unit in the Tuzla district of Istanbul. The healthy participant population will consist of healthy male and female individuals residing in Istanbul, between the ages of 20 and 65, who have not been diagnosed with obesity.

You may qualify if:

  • Between the ages of 20-65
  • With BMI\>30 kg/m\^2
  • Between the ages of 20-65
  • With BMI\<30 kg/m\^2

You may not qualify if:

  • Pregnancy
  • Uncontrollable hypertension
  • Uncontrolled diabetes requires the use of insulin
  • Chronic lung diseases (COPD, etc.)
  • Heart failure
  • Cognitive and motor disorders
  • Orthopedic and neurological dysfunctions that may interfere with evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

ObesityMotor ActivitySleep Apnea SyndromesAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavioral Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assoc. Prof. Goksen Kuran Aslan

Study Record Dates

First Submitted

September 24, 2021

First Posted

October 21, 2021

Study Start

September 4, 2021

Primary Completion

September 4, 2022

Study Completion

December 4, 2022

Last Updated

August 16, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations